02Aug
FDA Issues Cannabidiol Marketing Warning as Congressional Pressure for Action Continues
Following through with its promise to take enforcement actions against companies marketing cannabis-derived products that could put consumers at risk, the Food and Drug Administration (FDA) recently issued a warning letter to Curaleaf Inc., a...
By:
Wilson Sonsini Goodrich & Rosati
Related
With the increasing reliance of U.S. employers on high-skilled foreign workers, particularly those o...
Read More >
Ken Fisher of Fisher Investments is facing almost $2 billion of withdrawals from his firm as a resul...
Read More >
In March of this year, New York State issued restrictions on the operation of all businesses, provid...
Read More >
What are some of the key FCPA enforcement actions involving M&A? These enforcement actions, FCPA Re...
Read More >
New Act 250 board proposal is gutted - The House Committee on Ways and Means voted 9-1 this week in...
Read More >
Textile Manufacturer Discriminated Against Experienced Sales Leader By Firing Him After Learning His...
Read More >